SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-052532
Filing Date
2023-10-10
Accepted
2023-10-10 16:38:21
Documents
2
Period of Report
2023-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1557
2 EX-24 DOCUMENT attachment1.htm EX-24 3518
  Complete submission text file 0001209191-23-052532.txt   6386
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address
Lagarde Michel (Reporting) CIK: 0001518973 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 231318430